Founders Fund

Founders Fund, Inc. is a venture capital firm headquartered in San Francisco, California, established in 2005. The firm specializes in investing across various stages, including seed, early, mid, and growth stages, with a focus on transformative technologies. Founders Fund targets a wide range of sectors, such as aerospace, artificial intelligence, advanced computing, biotechnology, cybersecurity, energy, fintech, and consumer internet. The firm aims to support companies that are developing revolutionary technologies and typically invests between $500,000 and $300 million in its portfolio companies. Founders Fund's partners have a strong background in technology, having been investors, founders, and early employees of notable technology companies, including PayPal. The firm seeks to make investments globally, emphasizing innovation and impact.

Delian Asparouhov

Principal

Leigh Marie Braswell

Principal

Lauren Gross

Partner and COO

Jeffrey Lonsdale

Managing Director, Asia

John Luttig

Principal

Amin Mirzadegan

Principal

Scott Nolan

Partner

Luke Nosek

Managing Partner

Neil Ruthven

CFO

Brian Singerman

Partner

Napoleon Ta

Partner

Matias Van Thienen

Principal

Past deals in Health Diagnostics

Even

Series A in 2024
Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.

Q Bio

Venture Round in 2024
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.

9amHealth

Series A in 2024
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Forward

Series E in 2023
Forward is a startup redesigning the way healthcare is delivered using all the technologies healthcare has neglected such as sensors, mobile, and AI. Forward was founded in January 2016 by former executives and engineering leaders from Google and Uber and led by serial entrepreneur Adrian Aoun. Forward is funded by investors and entrepreneurs including First Round Capital, Eric Schmidt (Google/Alphabet chairman), Marc Benioff (Salesforce founder), Joe Lonsdale (Palantir founder), Joshua Kushner (Oscar co-founder), and Garrett Camp (Uber co-founder).

Mendaera

Series A in 2023
Mendaera is a medtech startup that specializes in developing advanced healthcare technologies, with a focus on robotics and diagnostic tools. The company aims to enhance clinical judgment and technical expertise to make high-quality care accessible to all patients across various care facilities. Mendaera's innovative platform, currently in development, combines real-time imaging, robotics, and artificial intelligence to assist physicians in both image acquisition and interpretation. This integration facilitates precise and consistent point-of-care interventions, streamlining the patient journey, accelerating recovery, and reducing overall care costs. By empowering healthcare professionals with these advanced technologies, Mendaera seeks to improve the efficacy and accessibility of medical procedures.

Even

Convertible Note in 2022
Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.

Nucleus

Seed Round in 2022
Nucleus operates a biotechnology research platform focused on next-generation consumer genetic testing and analysis. The company allows users to upload their genetic information obtained from established providers and employs proprietary algorithms to calculate polygenic risk scores and assess disease risk based on genetic variants. Utilizing whole-genome sequencing, Nucleus delivers comprehensive genetic analysis, facilitating advancements in human health and medicine. The results are presented on a user-friendly platform, making complex genetic information accessible and understandable for users.

Ostro

Series B in 2022
Ostro is a health platform that specializes in personalized engagement solutions for the life sciences sector. Established in 2019 and headquartered in Miami, Florida, Ostro connects the creators of medicines with their users, enhancing healthcare journeys for both consumers and healthcare professionals. The platform facilitates a streamlined patient experience by integrating virtual consultations, logistics, regulatory compliance, and payment services. Through its innovative approach, Ostro aims to improve health outcomes by fostering informed connections and driving engagement, ultimately benefiting patients and life sciences brands alike.

9amHealth

Series A in 2022
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Cor

Series A in 2022
COR helps you implement globally-proven healthy lifestyle practices, then shows you a totally new type of data about how your body responds. Optimize your lifestyle and discover the impact of different daily customs with precise, science-based self-knowledge.

Alinea Health

Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.

Sword Health

Series D in 2021
Sword Health is a digital health company focused on revolutionizing physical rehabilitation through its advanced artificial intelligence care platform. The company aims to alleviate pain for billions of people by providing a unique solution that combines the expertise of physical therapy professionals with an interactive AI experience. This platform enables patients to access customized rehabilitation exercises from their homes, allowing them to receive supervised care anytime and anywhere. Sword Health's approach not only enhances patient independence but also offers valuable data to clinical teams and decision-makers, ultimately improving clinical and cost-saving outcomes in the field of physical therapy.

Teiko.bio

Venture Round in 2021
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response. The company was founded in 2020 and is based in Salt Lake City, Utah.

9amHealth

Seed Round in 2021
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

HeartLab

Seed Round in 2021
HeartLab is a leader in cardiac imaging, focusing on the development of AI-based diagnostic tools that assist healthcare professionals in diagnosing and treating cardiovascular diseases. The company offers an integrated platform that streamlines the end-to-end imaging workflow, enhancing collaboration and efficiency among medical teams. HeartLab's advanced deep learning technologies enable doctors to extract detailed information from echocardiograms while automating repetitive tasks associated with measurement processes. This innovation allows clinicians to conduct echocardiograms and interpret results more swiftly, ultimately promoting faster advancements in cardiology and improving the experiences of healthcare practitioners worldwide.

Even

Seed Round in 2021
Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.

Sword Health

Series C in 2021
Sword Health is a digital health company focused on revolutionizing physical rehabilitation through its advanced artificial intelligence care platform. The company aims to alleviate pain for billions of people by providing a unique solution that combines the expertise of physical therapy professionals with an interactive AI experience. This platform enables patients to access customized rehabilitation exercises from their homes, allowing them to receive supervised care anytime and anywhere. Sword Health's approach not only enhances patient independence but also offers valuable data to clinical teams and decision-makers, ultimately improving clinical and cost-saving outcomes in the field of physical therapy.

Maximus

Seed Round in 2021
Maximus is a consumer telemedicine company for men’s health and hormone optimization. Maximus is revolutionizing the performance enhancement space by democratizing doctor-prescribed protocols developed by some of the world’s leading experts in men’s health. Maximus’ King Protocol utilizes a convenient prescription medication capsule to stimulate natural testosterone production, proven by at-home lab tests. Maximus was established in 2020 by Cameron Sepah in Santa Monica, California.

Clearing

Seed Round in 2021
Clearing is a digital healthcare platform built to serve the more than 50M chronic pain sufferers in the United States. In partnership with leading physicians and researchers at Harvard, Johns Hopkins, and the Hospital for Special Surgery, and with significant funding from top-tier investors Bessemer Venture Partners, Founders Fund, Breyer Capital, and a host of leading healthcare and consumer entrepreneurs (including the founders of Hims, Seamless Grubhub, Flatiron Health, Forward Health, Curology and more) we are on a mission to provide patients with access to comprehensive, opioid-free pain relief.

Forward

Series D in 2021
Forward is a startup redesigning the way healthcare is delivered using all the technologies healthcare has neglected such as sensors, mobile, and AI. Forward was founded in January 2016 by former executives and engineering leaders from Google and Uber and led by serial entrepreneur Adrian Aoun. Forward is funded by investors and entrepreneurs including First Round Capital, Eric Schmidt (Google/Alphabet chairman), Marc Benioff (Salesforce founder), Joe Lonsdale (Palantir founder), Joshua Kushner (Oscar co-founder), and Garrett Camp (Uber co-founder).

Sword Health

Series B in 2021
Sword Health is a digital health company focused on revolutionizing physical rehabilitation through its advanced artificial intelligence care platform. The company aims to alleviate pain for billions of people by providing a unique solution that combines the expertise of physical therapy professionals with an interactive AI experience. This platform enables patients to access customized rehabilitation exercises from their homes, allowing them to receive supervised care anytime and anywhere. Sword Health's approach not only enhances patient independence but also offers valuable data to clinical teams and decision-makers, ultimately improving clinical and cost-saving outcomes in the field of physical therapy.

Tempo

Series B in 2020
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Siren Care

Series B in 2020
Siren Care, Inc. is a health technology company based in San Francisco, California, founded in 2015. It specializes in wearable devices designed for diabetic health tracking, particularly through its flagship product, the Siren diabetic socks. These smart socks continuously monitor foot temperature, providing crucial data that can help detect early signs of diabetic ulcers, thereby reducing the risk of amputations. The temperature data is transmitted via an application, allowing healthcare providers to monitor patients effectively and intervene early if necessary. Siren Care aims to enhance healthcare for individuals with chronic diseases by collaborating with both providers and payers to improve patient outcomes in diabetic foot care.

Sword Health

Series A in 2020
Sword Health is a digital health company focused on revolutionizing physical rehabilitation through its advanced artificial intelligence care platform. The company aims to alleviate pain for billions of people by providing a unique solution that combines the expertise of physical therapy professionals with an interactive AI experience. This platform enables patients to access customized rehabilitation exercises from their homes, allowing them to receive supervised care anytime and anywhere. Sword Health's approach not only enhances patient independence but also offers valuable data to clinical teams and decision-makers, ultimately improving clinical and cost-saving outcomes in the field of physical therapy.

Q Bio

Series B in 2020
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.

Ostro

Series A in 2019
Ostro is a health platform that specializes in personalized engagement solutions for the life sciences sector. Established in 2019 and headquartered in Miami, Florida, Ostro connects the creators of medicines with their users, enhancing healthcare journeys for both consumers and healthcare professionals. The platform facilitates a streamlined patient experience by integrating virtual consultations, logistics, regulatory compliance, and payment services. Through its innovative approach, Ostro aims to improve health outcomes by fostering informed connections and driving engagement, ultimately benefiting patients and life sciences brands alike.

Scanwell Health

Seed Round in 2019
Scanwell Health, Inc. designs and develops an innovative urine testing kit that provides clinical-grade results through a smartphone application. Founded in 2018 and headquartered in Los Angeles, California, the company offers a urinary tract infection test kit that is FDA-cleared. This product allows users to receive same-day test results and connect with an online doctor’s office for immediate treatment and prescription of antibiotics. By facilitating accessible and affordable healthcare, Scanwell Health aims to empower individuals to take charge of their health proactively.

Tempo

Series A in 2019
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Collective Health

Series E in 2019
Collective Health is a prominent health benefits platform that streamlines the management of medical, dental, vision, and pharmacy services for employees and their families. By offering an integrated solution through a cloud-based self-insurance platform, the company simplifies the administration of health plans via a single portal. This platform provides users with clear guidance, live concierge support, and digital tools to facilitate the navigation and management of healthcare services. Collective Health aims to reduce the complexities of delivering health benefits, enhance the member experience, and promote healthier outcomes for both employees and organizations. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Siren Care

Series A in 2018
Siren Care, Inc. is a health technology company based in San Francisco, California, founded in 2015. It specializes in wearable devices designed for diabetic health tracking, particularly through its flagship product, the Siren diabetic socks. These smart socks continuously monitor foot temperature, providing crucial data that can help detect early signs of diabetic ulcers, thereby reducing the risk of amputations. The temperature data is transmitted via an application, allowing healthcare providers to monitor patients effectively and intervene early if necessary. Siren Care aims to enhance healthcare for individuals with chronic diseases by collaborating with both providers and payers to improve patient outcomes in diabetic foot care.

Vium

Series B in 2018
Vium, Inc. is a biotechnology company focused on transforming preclinical research and enhancing animal welfare through the development of digital biomarkers. Fully accredited by AAALAC International, Vium has received commendation for its commitment to the principles of humane animal research. The company's platform, known as Digital Vivarium and Vium Cloud, integrates advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively capture and analyze physiological metrics and behaviors. This innovative approach provides researchers across biotechnology, pharmaceutical, and academic sectors with accurate data that facilitates better decision-making regarding which compounds to advance to clinical trials. Founded in 2013 and headquartered in San Mateo, California, Vium aims to accelerate the preclinical drug discovery and development pipeline while ensuring ethical standards in research practices.

CTRL-Labs

Series B in 2018
CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.

Virta Health

Series B in 2018
Virta Health Corp. is an online specialty medical clinic dedicated to reversing type 2 diabetes without the use of medications or surgery. Founded in 2014 and based in San Francisco, California, the company utilizes a combination of nutritional biochemistry, clinical expertise, data science, and digital solutions to deliver its innovative treatment. Through its continuous remote care platform, Virta provides extensive medical and behavioral support, which has shown significant results in clinical trials; 60% of enrolled patients achieved diabetes reversal after one year, while 94% of insulin users reduced or eliminated their insulin intake. The benefits of Virta's approach extend beyond diabetes, leading to improvements in blood pressure, inflammation, liver function, and body mass index (BMI), thereby transforming the lives of individuals affected by type 2 diabetes.

Siren Care

Seed Round in 2018
Siren Care, Inc. is a health technology company based in San Francisco, California, founded in 2015. It specializes in wearable devices designed for diabetic health tracking, particularly through its flagship product, the Siren diabetic socks. These smart socks continuously monitor foot temperature, providing crucial data that can help detect early signs of diabetic ulcers, thereby reducing the risk of amputations. The temperature data is transmitted via an application, allowing healthcare providers to monitor patients effectively and intervene early if necessary. Siren Care aims to enhance healthcare for individuals with chronic diseases by collaborating with both providers and payers to improve patient outcomes in diabetic foot care.

Neurotrack

Series B in 2018
Neurotrack is a digital health company focused on transforming the diagnosis and management of Alzheimer's and other dementias. Founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola, the company is headquartered in Redwood City, California. Neurotrack develops user-friendly, clinically validated cognitive assessments that can be administered in clinical settings or at home, allowing for early detection of cognitive impairment and ongoing monitoring of cognitive function. The company's solutions are designed to fit seamlessly into various workflows, enabling healthcare providers to efficiently screen patients for cognitive decline and take necessary next steps. Neurotrack has published 27 peer-reviewed papers, holds 11 patents for its proprietary technology, and is registered as an FDA Class II medical device.

Collective Health

Series D in 2018
Collective Health is a prominent health benefits platform that streamlines the management of medical, dental, vision, and pharmacy services for employees and their families. By offering an integrated solution through a cloud-based self-insurance platform, the company simplifies the administration of health plans via a single portal. This platform provides users with clear guidance, live concierge support, and digital tools to facilitate the navigation and management of healthcare services. Collective Health aims to reduce the complexities of delivering health benefits, enhance the member experience, and promote healthier outcomes for both employees and organizations. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Neurotrack

Series A in 2016
Neurotrack is a digital health company focused on transforming the diagnosis and management of Alzheimer's and other dementias. Founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola, the company is headquartered in Redwood City, California. Neurotrack develops user-friendly, clinically validated cognitive assessments that can be administered in clinical settings or at home, allowing for early detection of cognitive impairment and ongoing monitoring of cognitive function. The company's solutions are designed to fit seamlessly into various workflows, enabling healthcare providers to efficiently screen patients for cognitive decline and take necessary next steps. Neurotrack has published 27 peer-reviewed papers, holds 11 patents for its proprietary technology, and is registered as an FDA Class II medical device.

Q Bio

Seed Round in 2016
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.

Collective Health

Series B in 2015
Collective Health is a prominent health benefits platform that streamlines the management of medical, dental, vision, and pharmacy services for employees and their families. By offering an integrated solution through a cloud-based self-insurance platform, the company simplifies the administration of health plans via a single portal. This platform provides users with clear guidance, live concierge support, and digital tools to facilitate the navigation and management of healthcare services. Collective Health aims to reduce the complexities of delivering health benefits, enhance the member experience, and promote healthier outcomes for both employees and organizations. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Collective Health

Series B in 2015
Collective Health is a prominent health benefits platform that streamlines the management of medical, dental, vision, and pharmacy services for employees and their families. By offering an integrated solution through a cloud-based self-insurance platform, the company simplifies the administration of health plans via a single portal. This platform provides users with clear guidance, live concierge support, and digital tools to facilitate the navigation and management of healthcare services. Collective Health aims to reduce the complexities of delivering health benefits, enhance the member experience, and promote healthier outcomes for both employees and organizations. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Sols

Series B in 2015
SOLS is a software platform and mobile application that enables users to design and purchase customized orthotics for their feet. To date, the company has launched two products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct to consumer custom insoles. SOLS is now leveraging its patented footwear customization software to attack the footwear industry's biggest problem, shoe size-related returns. Founded in 2013, SOLS uses state of the art computer vision and machine learning to improve the fit and function of footwear. The company is backed by blue-chip investors like Founders Fund, Lux Capital, and Tenaya Capital and located in New York City.

Misfit Wearables

Series C in 2014
Misfit is focused on developing great wearable products: things that people would want to wear all the time for a long time. A pioneer in the emerging world of wearable sensor technology, the company is making products and services in the consumer health and fitness space to inspire people to be more active and develop healthy habits. Misfit’s first product is the Shine, an elegant personal activity tracker that can instantly sync with a smartphone just by placing the device on the screen. Misfit was founded in 2011 and headquartered in Burlingame, California.

Vium

Series A in 2014
Vium, Inc. is a biotechnology company focused on transforming preclinical research and enhancing animal welfare through the development of digital biomarkers. Fully accredited by AAALAC International, Vium has received commendation for its commitment to the principles of humane animal research. The company's platform, known as Digital Vivarium and Vium Cloud, integrates advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively capture and analyze physiological metrics and behaviors. This innovative approach provides researchers across biotechnology, pharmaceutical, and academic sectors with accurate data that facilitates better decision-making regarding which compounds to advance to clinical trials. Founded in 2013 and headquartered in San Mateo, California, Vium aims to accelerate the preclinical drug discovery and development pipeline while ensuring ethical standards in research practices.

Sols

Series A in 2014
SOLS is a software platform and mobile application that enables users to design and purchase customized orthotics for their feet. To date, the company has launched two products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct to consumer custom insoles. SOLS is now leveraging its patented footwear customization software to attack the footwear industry's biggest problem, shoe size-related returns. Founded in 2013, SOLS uses state of the art computer vision and machine learning to improve the fit and function of footwear. The company is backed by blue-chip investors like Founders Fund, Lux Capital, and Tenaya Capital and located in New York City.

Collective Health

Series A in 2014
Collective Health is a prominent health benefits platform that streamlines the management of medical, dental, vision, and pharmacy services for employees and their families. By offering an integrated solution through a cloud-based self-insurance platform, the company simplifies the administration of health plans via a single portal. This platform provides users with clear guidance, live concierge support, and digital tools to facilitate the navigation and management of healthcare services. Collective Health aims to reduce the complexities of delivering health benefits, enhance the member experience, and promote healthier outcomes for both employees and organizations. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Misfit Wearables

Series B in 2013
Misfit is focused on developing great wearable products: things that people would want to wear all the time for a long time. A pioneer in the emerging world of wearable sensor technology, the company is making products and services in the consumer health and fitness space to inspire people to be more active and develop healthy habits. Misfit’s first product is the Shine, an elegant personal activity tracker that can instantly sync with a smartphone just by placing the device on the screen. Misfit was founded in 2011 and headquartered in Burlingame, California.

Neurotrack

Seed Round in 2013
Neurotrack is a digital health company focused on transforming the diagnosis and management of Alzheimer's and other dementias. Founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola, the company is headquartered in Redwood City, California. Neurotrack develops user-friendly, clinically validated cognitive assessments that can be administered in clinical settings or at home, allowing for early detection of cognitive impairment and ongoing monitoring of cognitive function. The company's solutions are designed to fit seamlessly into various workflows, enabling healthcare providers to efficiently screen patients for cognitive decline and take necessary next steps. Neurotrack has published 27 peer-reviewed papers, holds 11 patents for its proprietary technology, and is registered as an FDA Class II medical device.

Natera

Series E in 2013
Natera, Inc. is a diagnostic company that specializes in preconception and prenatal genetic testing services. Its primary offerings include the Panorama test, which is a non-invasive prenatal test that screens for chromosomal abnormalities in a fetus through a blood sample from the mother, and the Vistara test, designed to identify single-gene disorders. Additionally, Natera provides Horizon carrier screening to determine genetic disease carrier status and Spectrum, which analyzes chromosomal anomalies during in vitro fertilization. The company also offers Anora, a test for analyzing fetal chromosomes to investigate miscarriage causes, and non-invasive paternity testing. Its Signatera product utilizes circulating tumor DNA technology to monitor cancer recurrence. Natera markets its tests through a direct sales force and a network of approximately 100 laboratory and distribution partners both domestically and internationally. The company, founded in 2003 and headquartered in San Carlos, California, maintains partnerships with BGI Genomics and Foundation Medicine for the development of genetic testing assays.

Ringadoc

Venture Round in 2013
Ringadoc is transforming the way doctors communicate virtually with patients. The company provides cross-platform communication software for healthcare professionals, their patients, office staff, and cross-coverage providers. Leveraging existing technology and natural behavior Ringadoc brings doctors and patients closer than ever while making the lives of healthcare professionals easier. Ringadoc is led by Founder and CEO Jordan Michaels.

Practice Fusion

Series C in 2012
Practice Fusion, Inc. is a cloud-based electronic health records (EHR) company based in San Francisco, California, founded in 2005. The company provides a comprehensive practice management software platform that includes features such as charting, scheduling, billing, e-prescribing, lab integrations, and secure messaging. This platform is designed to connect medical professionals, patients, labs, billers, imaging centers, and life science partners, facilitating improved healthcare delivery. Additionally, Practice Fusion offers a healthcare database called Practice Fusion Insight to support medical professionals. Its services cater to a diverse range of users, including independent practices, community clinics, large medical groups, and non-profit organizations. As of February 2018, Practice Fusion operates as a subsidiary of Allscripts Healthcare Solutions.

Misfit Wearables

Series A in 2012
Misfit is focused on developing great wearable products: things that people would want to wear all the time for a long time. A pioneer in the emerging world of wearable sensor technology, the company is making products and services in the consumer health and fitness space to inspire people to be more active and develop healthy habits. Misfit’s first product is the Shine, an elegant personal activity tracker that can instantly sync with a smartphone just by placing the device on the screen. Misfit was founded in 2011 and headquartered in Burlingame, California.

100Plus

Seed Round in 2011
100Plus is a rapidly growing remote patient monitoring platform designed to enhance the care of elderly patients with chronic conditions. The platform provides comprehensive services, including patient outreach, device setup, patient engagement, and automatic billing, all integrated with medical devices. By enabling doctors to monitor high-risk seniors remotely, 100Plus helps to prevent costly episodic care and promotes a higher quality of life for patients. When a Medicare patient receives a 100Plus medical device, it is delivered at no cost to them or their healthcare providers, fully configured and ready for immediate use, eliminating the need for smartphones, apps, Bluetooth, or WiFi.

Practice Fusion

Venture Round in 2011
Practice Fusion, Inc. is a cloud-based electronic health records (EHR) company based in San Francisco, California, founded in 2005. The company provides a comprehensive practice management software platform that includes features such as charting, scheduling, billing, e-prescribing, lab integrations, and secure messaging. This platform is designed to connect medical professionals, patients, labs, billers, imaging centers, and life science partners, facilitating improved healthcare delivery. Additionally, Practice Fusion offers a healthcare database called Practice Fusion Insight to support medical professionals. Its services cater to a diverse range of users, including independent practices, community clinics, large medical groups, and non-profit organizations. As of February 2018, Practice Fusion operates as a subsidiary of Allscripts Healthcare Solutions.

Azumio

Series A in 2011
Azumio Inc. is a Palo Alto, California-based developer of health and fitness mobile applications aimed at improving overall human health. Founded in 2011, the company offers a range of applications, including Instant Heart Rate, Fitness Buddy, and the Argus platform. Argus serves as a comprehensive lifestyle service that facilitates activity and diet tracking while fostering a social network centered on health and fitness. The platform integrates various applications, such as Sleep Time and Glucose Buddy, and also connects with third-party wearable devices. Azumio leverages advanced technologies, including AI and deep learning, to enhance food recognition and provide users with valuable insights into their health and wellbeing.

Practice Fusion

Series B in 2011
Practice Fusion, Inc. is a cloud-based electronic health records (EHR) company based in San Francisco, California, founded in 2005. The company provides a comprehensive practice management software platform that includes features such as charting, scheduling, billing, e-prescribing, lab integrations, and secure messaging. This platform is designed to connect medical professionals, patients, labs, billers, imaging centers, and life science partners, facilitating improved healthcare delivery. Additionally, Practice Fusion offers a healthcare database called Practice Fusion Insight to support medical professionals. Its services cater to a diverse range of users, including independent practices, community clinics, large medical groups, and non-profit organizations. As of February 2018, Practice Fusion operates as a subsidiary of Allscripts Healthcare Solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.